FDA Inspection 1219423 — Sichuan Deebio Pharmaceutical Co., Ltd.
The FDA completed an inspection of Sichuan Deebio Pharmaceutical Co., Ltd. on Sep 8, 2023 in Guanghan. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Sep 8, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Guanghan (China)